Academics might have increased public anxiety and demand for flu drugs.
Analysis of UK media reporting of the 2009/10 A/H1N1 influenza pandemic has found that public health academics with links to pharmaceutical companies were more likely than other academics to assess the risk to the public as higher than official predictions.